Elsevier

The Lancet

Volume 335, Issue 8691, 24 March 1990, Pages 675-679
The Lancet

MEDICAL SCIENCE
Increased expression of mutant forms of p53 oncogene in primary lung cancer

https://doi.org/10.1016/0140-6736(90)90801-BGet rights and content

Abstract

Primary lung cancer samples of the major histological types were examined for expression of the tumour suppressor gene p53 by immunohistochemistry. Abnormalities in p53 expression were found in 28 of 40 carcinomas, 14 of 17 squamous tumours showing abnormal p53 expression, whereas no expression of p53 was detectable in 7 carcinoid tumours or in 10 normal lung samples. Direct evidence for homozygous expression of mutant p53 mRNA in representative carcinomas was obtained by means of an asymmetric polymerase chain reaction mRNA sequencing strategy, which allowed sequencing without any cloning step. All the mutations were G to Ttransversions resulting in mis-sense mutations in aminoacids highly conserved in evolution. Mutation of the p53 gene is the most frequently identified genetic change in human lung cancer; these findings suggest that simple immunohistological methods can provide strong evidence of such mutation.

References (30)

  • Ca Finlay et al.

    The p53 proto-oncogene can act as a suppressor of transformation

    Cell

    (1989)
  • A. Zantema et al.

    Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies

    Virology

    (1985)
  • S. Rodenhuis et al.

    K-ras oncogene activation in adenocarcinoma of the lung: incidence and possible clinical significance

    Cancer Res

    (1988)
  • K. Saksela et al.

    Oncogene expression in small-cell lung cancer cell lines and a testicular germ-cell tumour: activation of the N-myc gene and decreased RB mRNA

    Int J cancer

    (1989)
  • Ms Berger et al.

    Epidermal growth factor receptors in lung tumours

    J Pathol

    (1987)
  • D. Veale et al.

    Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer

    Cancer Res

    (1989)
  • Dp Lane et al.

    T-antigen is bound to a host protein in SV40 transformed cells

    Nature

    (1979)
  • P. Hinds et al.

    Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

    J Virol

    (1989)
  • T. Soussi et al.

    Cloning and charactensation of a cDNA from Xenopus laevis coding for a protein homolgous to human and murine p53

    Oncogene

    (1987)
  • Ca Finlay et al.

    Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

    Mol Cell Biol

    (1988)
  • H-W. Sturzbecher et al.

    Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells

    Oncogene

    (1987)
  • Sj Baker et al.

    Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

    Science

    (1989)
  • T. Takahashi et al.

    p53: a frequent target for genetic abnormalities in lung cancer

    Science

    (1989)
  • Ms Dunnill et al.

    Cellular heterogeneity m lung cancer

    Histopathology

    (1986)
  • Cited by (0)

    View full text